Journal Article10.1111/1346-8138.13081
TUR-PSO: A cross-sectional, study investigating quality of life and treatment status of psoriasis patients in Turkey
Nilgün Atakan,Ayça Cordan Yazici,Güzin Özarmağan,Huseyin Serhat Inaloz,Mehmet Ali Gürer,İlham Sabuncu,Ümmühan Kİremİtçİ,Sibel Alper,Sema Aytekin,Ozer Arican,Mualla Polat,Sibel Dogan,Emre Aldinc +12 more
TL;DR: The demographic and clinical characteristics, quality of life and treatment patterns of psoriasis patients in Turkey, a country with a population of 76 million, were defined and the most severely affected component of EQ‐5D was anxiety/depression.
read more
Abstract: Psoriasis is a common inflammatory disease that has a severe impact on quality of life. There is lack of data regarding epidemiological and clinical features of psoriasis patients in Turkey, a country with a population of 76 million. The aim of this study was to define the demographic and clinical characteristics, quality of life and treatment patterns of psoriasis patients in Turkey. A cross-sectional observational study was conducted at 40 centers, chosen from geographically diverse locations in Turkey. Patients diagnosed with psoriasis were assessed by investigators who were specialists of dermatology using standardized study questionnaire forms. Dermatology Life Quality Index (DLQI) and EuroQol-5 dimension (EQ-5D) forms were also filled out by each patient. 3971 psoriasis patients were included in this study. 24.2% of plaque psoriasis patients had moderate to severe psoriasis (Psoriasis Area and Severity Index, ≥10). Mean DLQI was 7.03 ± 6.02; quality of life was moderately, severely or very severely affected in 49.2% of patients. The most severely affected component of EQ-5D was anxiety/depression. Among all patients, 22.9% were not receiving any treatment, 39.8% were receiving only topical treatment, 11.5% were on phototherapy, 26.1%, were taking conventional systemic agents and 4.1% were on a biologic treatment. 31.3% of psoriasis patients with moderate to severe disease were treated with only topical agents and only 30.5% of moderate to severe psoriasis patients were receiving systemic therapy. Moderate to severe psoriasis has a considerable impact on quality of life. Treatment in Turkey of patients with moderate to severe psoriasis is insufficient.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Highlighting interleukin-36 signalling in plaque psoriasis and pustular psoriasis
Kazuhisa Furue,Kazuhiko Yamamura,Gaku Tsuji,Chikage Mitoma,Hiroshi Uchi,Takeshi Nakahara,Makiko Kido-Nakahara,Takafumi Kadono,Masutaka Furue +8 more
TL;DR: This review summarizes current topics on how IL-36 agonists signalIL-36R, the pathological expression of IL- 36 agonists and IL-37Ra in plaque and pustular psoriatic lesions, and the cross-talk between the TNF-?/IL-23/il-17/ IL-22 axis and the functional activation of IL -36R in the epidermal milieu.
Autoimmunity and autoimmune co-morbidities in psoriasis.
TL;DR: The recent topics on autoimmunity and autoimmune co‐morbidities in psoriasis are reviewed.
69
The Psoriatic Arthritis Registry of Turkey: results of a multicentre registry on 1081 patients
Umut Kalyoncu,Ozun Bayindir,Mustafa Ferhat Öksüz,Atalay Dogru,Gezmiş Kimyon,Emine Figen Tarhan,Abdulsamet Erden,Sule Yavuz,Meryem Can,Gozde Yildirim Cetin,Levent Kılıç,Orhan Küçükşahin,Ahmet Omma,Cem Ozisler,Dilek Solmaz,Emine Duygu Ersözlü Bozkirli,Lütfi Akyol,Seval Pehlevan,Esen Kasapoglu Gunal,Fatos Arslan,Baris Yilmazer,Nilgün Atakan,Sibel Zehra Aydin +22 more
TL;DR: The PsA registry of Turkey had similarities with previously published registries, supporting its external validity and the finding that women had more fatigue and worse functioning as well as the high percentage of active disease state highlight the unmet need in treatment of PsA.
Health-related quality of life and perceived health status of Turkish population
Gönül Dinç Horasan,Kevser Tarı Selçuk,Sibel Sakarya,Kaan Sözmen,Gül Ergör,Nazan Yardim,G Sarioglu,Meltem Soylu,Bekir Keskinkılıç,Turan Buzgan,U Hulur,H Ekinci,B Ekinci,Belgin Ünal +13 more
TL;DR: The perceived health level and HRQOL is worse in women, in older age groups, in people from lower socioeconomical status and the most important determinants of having a problem in any of the five dimensions are age, gender, education, diabetes mellitus, coronary heart disease, stroke, alzheimer, cancer, renal failure.
12
The effect of illness perception on life quality in psoriasis patients.
TL;DR: The quality of life of the psoriasis patients who associated their symptoms with the disease, who had a high PASI score, thought that they were adversely affected by the Disease, and who saw personal attributions as the cause of the disease was negatively affected.
10
References
Pathogenesis and clinical features of psoriasis.
TL;DR: Comorbidities of psoriasis are attracting interest, and include impairment of quality of life and associated depressive illness, cardiovascular disease, and a seronegative arthritis known as psoriatic arthritis.
1.9K
Psoriasis causes as much disability as other major medical diseases.
TL;DR: Different aspects of psoriasis are related to the different dimensions of HRQL supporting the need for multidimensional treatment models, similar to that of other major medical diseases.
1.5K
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics
Alan Menter,Alice B. Gottlieb,Steven R. Feldman,Abby S. Van Voorhees,Craig L. Leonardi,Kenneth B. Gordon,Mark Lebwohl,John Koo,Craig A. Elmets,Neil J. Korman,Karl R. Beutner,Reva Bhushan +11 more
TL;DR: The classification of psoriasis; associated comorbidities including autoimmune diseases, cardiovascular risk, psychiatric/psychologic issues, and cancer risk; along with assessment tools for skin disease and quality-of-life issues; and the safety and efficacy of the biologic treatments used to treat patients with Psoriasis are discussed.
1.1K
Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis
TL;DR: It is indicated that in some instances even clinically mild to moderate disease such as non‐cystic facial acne can be associated with significant depression and suicidal ideation.
870
Translating the science of quality of life into practice: what do dermatology life quality index scores mean?
TL;DR: Banding of theDLQI will aid the clinical interpretation of an individual's DLQI score and allow DLQi scores to inform clinical decisions.
814